ArtiQ NV
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ArtiQ NV - overview
Established
2019
Location
Leuven, -, Belgium
Primary Industry
Healthcare IT
About
Founded in 2019 and based in Leuven, Belgium, ArtiQ NV operates as a health-tech company that provides an automated interpretation platform for pulmonary function tests to evaluate the patient's lung function and diagnose pulmonary diseases. Some of the firm's partners are EIT Health, NHS, Clario, Vyaire Medical, AstraZeneca, etc. In April 2024, Clario, a portfolio company of Nordic Capital, Novo Holdings, Cinven, and Astorg, acquired ArtiQ NV from UZ LEUVEN, KBC Group, and K. U.
The firm as of July 2024, is led by its co-founders, Marko Topalovic (CEO), Marko Topalovic (Board Member), Bart Swaelens (Strategic Development), and Wim (Board Member, Medical & Scientific Advisor). The company offers a range of AI-driven products tailored to respiratory care and clinical research, to enhance diagnostic accuracy and streamline clinical trials. These include ArtiQ. PFT, ArtiQ.
QC, and ArtiQ. PFT. ArtiQ. RBM provides automated support for interpreting pulmonary function tests, ensuring consistency and adherence to the latest guidelines.
ArtiQ. QC delivers real-time AI-based over-reading for spirometry, enhancing data quality and reducing variability. ArtiQ. RBM focuses on risk-based monitoring, aiming to safeguard data integrity in clinical trials.
Current Investors
K.U. Leuven Research & Development, KBC Group, UZ LEUVEN
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Website
www.artiq.eu
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
ArtiQ NV - timeline of key events
ArtiQ NV - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - |
| EBITDA (USD) | (112,943) | (141,328) | - | - | - |
| Operating Income (USD) | (182,068) | (218,880) | - | - | - |
| Operating Margin | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | (183,099) | (206,677) | - | - | - |
| % Net Margin | - | - | - | - | - |
ArtiQ NV - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | ArtiQ NV | - |
Displaying 1 - 1 of 1
ArtiQ NV - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.